↓ Skip to main content

Clonazepam for neuropathic pain and fibromyalgia in adults

Overview of attention for article published in Cochrane database of systematic reviews, May 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter
18 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
125 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clonazepam for neuropathic pain and fibromyalgia in adults
Published in
Cochrane database of systematic reviews, May 2012
DOI 10.1002/14651858.cd009486.pub2
Pubmed ID
Authors

Ruth Corrigan, Sheena Derry, Philip J Wiffen, R Andrew Moore

Abstract

Antiepileptic drugs have been used in pain management since the 1960s; some have shown efficacy in treating different neuropathic pain conditions. Clonazepam, a benzodiazepine, is an established antiepileptic drug, but its place in the treatment of neuropathic pain is unclear.

Twitter Demographics

The data shown below were collected from the profiles of 18 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 125 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Germany 2 2%
Spain 1 <1%
Australia 1 <1%
Unknown 119 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 27 22%
Student > Bachelor 15 12%
Student > Postgraduate 14 11%
Student > Ph. D. Student 13 10%
Researcher 12 10%
Other 26 21%
Unknown 18 14%
Readers by discipline Count As %
Medicine and Dentistry 63 50%
Nursing and Health Professions 14 11%
Neuroscience 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Psychology 4 3%
Other 12 10%
Unknown 21 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2019.
All research outputs
#1,365,985
of 14,539,453 outputs
Outputs from Cochrane database of systematic reviews
#3,838
of 10,993 outputs
Outputs of similar age
#11,073
of 123,552 outputs
Outputs of similar age from Cochrane database of systematic reviews
#28
of 101 outputs
Altmetric has tracked 14,539,453 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,993 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.0. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 123,552 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.